{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T07:20:53Z","timestamp":1772090453170,"version":"3.50.1"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The survival benefit of implantable cardioverter-defibrillators (ICD) in patients with left ventricular assist device (LVAD) remains unproven. The VT-LVAD score was developed to stratify arrhythmic risk and may help identify patients most likely to benefit from ICD therapy. We aimed to retrospectively assess its ability to identify patients at higher risk of ventricular arrythmias and to describe ICD-related complications in a population of patients with ICD and LVAD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 63 primary continuous-flow LVAD implantation were performed at our institution between January 2010 and March 2020 were included and stratified by risk (VT-LVAD score &amp;lt;5 or \u22655). Thirty patients (47.6%) had a low\/intermediate risk VT-LVAD score (&amp;lt;5) (Group 1) and 33 (52.4%) a high\/very high-risk VT-LVAD (score \u22655) (Group 2). Patients either had a previous ICD or were implanted before discharge, unless transplanted urgently. Early postoperative outcomes, including in-hospital arrhythmic events with hemodynamic instability, were collected, along with long-term outcomes such as all-cause mortality, ICD therapies, and ICD-related complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Patients with a VT-LVAD score \u22655 were more likely to experience in-hospital ventricular arrhythmias (VAs) than those with score &amp;lt;5 (91% vs. 43%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001). These VAs occurred mainly in the first five postoperative days, often due to an underlying cause, and resulted in hemodynamic instability in 40% of VT-LVAD &amp;lt;5 patients vs. 50% in VT-LVAD \u22655 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.44). Long-term mortality was similar for VT-LVAD &amp;lt;5 and \u22655 respectively (21.7% vs. 37.0%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.59) and there was no difference in arrhythmic events, including ATP therapies (17% vs. 22%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.73) and appropriate (0% vs. 4%) or inappropriate shocks (9% vs. 11%). There was one early lead dislodgement requiring repositioning, but no other long-term ICD complications.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The findings of our study are exploratory and hypothesis-generating; while the VT-LVAD score identifies patients at higher early arrhythmic risk, long-term malignant VAs were rare in both groups, and no survival benefit of ICD therapy can be derived from this study.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1707002","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T06:54:17Z","timestamp":1772088857000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Implantable cardioverter-defibrillator use in patients with left ventricular assist device: prediction of ventricular arrhythmia using the VT-LVAD score"],"prefix":"10.3389","volume":"13","author":[{"given":"Emmanuelle","family":"Massie","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Cardiology, Montreal Heart Institute, Universit\u00e9 de Montr\u00e9al","place":["Montreal, QC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacinthe","family":"Boulet","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Cardiology, Montreal Heart Institute, Universit\u00e9 de Montr\u00e9al","place":["Montreal, QC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corrado","family":"De Marco","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Cardiology, Montreal Heart Institute, Universit\u00e9 de Montr\u00e9al","place":["Montreal, QC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Emmanuel","family":"Noly","sequence":"additional","affiliation":[{"name":"Department of Surgery, Montreal Heart Institute, Universit\u00e9 de Montr\u00e9al","place":["Montreal, QC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoan","family":"Lamarche","sequence":"additional","affiliation":[{"name":"Department of Surgery, Montreal Heart Institute, Universit\u00e9 de Montr\u00e9al","place":["Montreal, QC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blandine","family":"Mond\u00e9sert","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Cardiology, Montreal Heart Institute, Universit\u00e9 de Montr\u00e9al","place":["Montreal, QC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anique","family":"Ducharme","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Cardiology, Montreal Heart Institute, Universit\u00e9 de Montr\u00e9al","place":["Montreal, QC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.jacc.2012.12.038","article-title":"Heart failure-associated hospitalizations in the United States","volume":"61","author":"Blecker","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1161\/CIR.0b013e31823ac046","article-title":"Heart disease and stroke statistics\u20132012 update: a report from the American Heart Association","volume":"125","author":"Roger","year":"2012","journal-title":"Circulation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1136\/hrt.2003.025254","article-title":"Prediction and prevention of sudden cardiac death in heart failure","volume":"91","author":"Lane","year":"2005","journal-title":"Heart"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/hrt.2003.025270","article-title":"Clinical epidemiology of heart failure","volume":"93","author":"Mosterd","year":"2007","journal-title":"Heart"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e272","DOI":"10.1161\/CIR.0000000000000549","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1001\/jama.2022.16197","article-title":"Five-year outcomes in patients with fully magnetically levitated vs axial-flow left ventricular assist devices in the MOMENTUM 3 randomized trial","volume":"328","author":"Mehra","year":"2022","journal-title":"J Am Med Assoc"},{"key":"B7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11886-015-0617-5","article-title":"Management of ventricular arrhythmias in patients with mechanical ventricular support devices","volume":"17","author":"Healy","year":"2015","journal-title":"Curr Cardiol Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.hrthm.2018.01.017","article-title":"Management of cardiac implantable electronic devices in the presence of left ventricular assist devices","volume":"15","author":"Parikh","year":"2018","journal-title":"Heart Rhythm"},{"key":"B9","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.healun.2016.11.008","article-title":"The role of implantable cardioverter defibrillators in patients bridged to transplantation with a continuous-flow left ventricular assist device: a propensity score matched analysis","volume":"36","author":"Clerkin","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"B10","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1161\/CIRCEP.113.000457","article-title":"The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices","volume":"6","author":"Enriquez","year":"2013","journal-title":"Circ"},{"key":"B11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.cardfail.2011.10.020","article-title":"Survival benefit of implantable cardioverter-defibrillators in left ventricular assist device-supported heart failure patients","volume":"18","author":"Refaat","year":"2012","journal-title":"J Card Fail"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1016\/j.jacc.2013.04.020","article-title":"Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention?","volume":"61","author":"Garan","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.healun.2009.03.011","article-title":"Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II)","volume":"28","author":"Andersen","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"B14","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jacep.2018.04.014","article-title":"Management of arrhythmias and cardiac implantable electronic devices in patients with left ventricular assist devices","volume":"4","author":"Ho","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.healun.2012.09.013","article-title":"The 2013 international society for heart and lung transplantation guidelines for mechanical circulatory support: executive summary","volume":"32","author":"Feldman","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"B16","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.jchf.2016.08.003","article-title":"Time for MADIT-VAD? ICDs among LVAD patients","volume":"4","author":"Kociol","year":"2016","journal-title":"JACC Heart Fail"},{"key":"B17","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.jchf.2016.05.003","article-title":"Implantable cardioverter-defibrillator use in patients with left ventricular assist devices: a systematic review and meta-analysis","volume":"4","author":"Vakil","year":"2016","journal-title":"JACC Heart Fail"},{"key":"B18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ijcard.2016.12.148","article-title":"Presence of implantable cardioverter-defibrillators and wait-list mortality of patients supported with left ventricular assist devices as bridge to heart transplantation","volume":"231","author":"Younes","year":"2017","journal-title":"Int J Cardiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.tcm.2017.07.002","article-title":"Arrhythmias after left ventricular assist device implantation: incidence and management","volume":"28","author":"Kadado","year":"2018","journal-title":"Trends Cardiovasc Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1111\/j.1540-8159.2011.03159.x","article-title":"Twelve hours of sustained ventricular fibrillation supported by a continuous-flow left ventricular assist device","volume":"35","author":"Sims","year":"2012","journal-title":"Pacing Clin Electrophysiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1016\/j.cardfail.2022.09.007","article-title":"Hemodynamic aberrancies in left ventricular assist device associated heart failure syndromes","volume":"28","author":"Boulet","year":"2022","journal-title":"J Card Fail"},{"key":"B22","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/j.1540-8159.2009.02403.x","article-title":"Left ventricular mechanical assist devices and cardiac device interactions: an observational case series","volume":"32","author":"Foo","year":"2009","journal-title":"Pacing Clin Electrophysiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/ehf2.12255","article-title":"Subcutaneous implantable cardioverter defibrillator in patients awaiting cardiac transplantation or left ventricular assist device for refractory heart failure: a feasible alternative to transvenous device?","volume":"5","author":"Migliore","year":"2018","journal-title":"ESC Heart Fail"},{"key":"B24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.14503\/THIJ-14-4795","article-title":"No electromagnetic interference occurred in a patient with a HeartMate II left ventricular assist system and a subcutaneous implantable cardioverter-defibrillator","volume":"43","author":"Raman","year":"2016","journal-title":"Tex Heart Inst J"},{"key":"B25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s11897-019-00449-8","article-title":"Current review of implantable cardioverter defibrillator use in patients with left ventricular assist device","volume":"16","author":"Boulet","year":"2019","journal-title":"Curr Heart Fail Rep"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.jacep.2018.05.006","article-title":"Predictors and clinical impact of late ventricular arrhythmias in patients with continuous-flow left ventricular assist devices","volume":"4","author":"Galand","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/jce.14827","article-title":"Validation of the VT-LVAD score for prediction of late VAs in LVAD recipients","volume":"32","author":"Darma","year":"2021","journal-title":"J Cardiovasc Electrophysiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.jchf.2017.08.014","article-title":"Implantable cardioverter-defibrillators in patients with a continuous-flow left ventricular assist device: an analysis of the INTERMACS registry","volume":"5","author":"Clerkin","year":"2017","journal-title":"JACC Heart Fail"},{"key":"B29","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/j.1540-8159.2009.02569.x","article-title":"Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights","volume":"33","author":"Voigt","year":"2010","journal-title":"Pacing Clin Electrophysiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jchf.2017.09.008","article-title":"Implantable cardioverter-defibrillators in patients with left ventricular assist devices","volume":"5","author":"Pokorney","year":"2017","journal-title":"JACC Heart Fail"},{"key":"B31","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1161\/hc0502.103330","article-title":"Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks","volume":"105","author":"Schron","year":"2002","journal-title":"Circulation"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1001\/archinte.167.20.2226","article-title":"Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study","volume":"167","author":"Passman","year":"2007","journal-title":"Arch Intern Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"S362","DOI":"10.1016\/j.healun.2019.01.920","article-title":"ICD therapy in LVAD: rates and predictors of appropriate and inappropriate shock","volume":"38","author":"Dharmavaram","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e004633","DOI":"10.1161\/CIRCEP.116.004633","article-title":"Subcutaneous implantable cardioverter-defibrillator shocks after left ventricular assist device implantation","volume":"9","author":"Pfeffer","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jacep.2015.10.008","article-title":"Subcutaneous implantable cardioverter-defibrillator and left ventricular assist device: a safe and effective approach for refractory heart failure","volume":"2","author":"Migliore","year":"2016","journal-title":"JACC Clin Electrophysiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1056\/NEJMoa1915932","article-title":"Subcutaneous or transvenous defibrillator therapy","volume":"383","author":"Knops","year":"2020","journal-title":"N Engl J Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.7326\/M22-1566","article-title":"Perioperative safety and early patient and device outcomes among subcutaneous versus transvenous implantable cardioverter defibrillator implantations: a randomized, multicenter trial","volume":"175","author":"Healey","year":"2022","journal-title":"Ann Intern Med"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1707002\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T06:54:18Z","timestamp":1772088858000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1707002\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":37,"alternative-id":["10.3389\/fcvm.2026.1707002"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1707002","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"article-number":"1707002"}}